Combination therapy of an anti-CD20 antibody with a Bcl-2 inhibitor and a MDM2 inhibitor

• 收藏
• 分享

专利权人:

Hoffmann-La Roche Inc.

发明人:

Christian Klein,Frank Herting,Markus Dangl

申请号：

US15166149

公开号：

US20160347852A1

申请日:

2016.05.26

申请国别(地区):

US

年份:

2016

代理人:

摘要：

The present invention is directed to the combination therapy of an anti-CD20 antibody with a Bcl-2 inhibitor and a MDM2 inhibitor for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with a type I anti-CD20 antibody or an afucosylated humanized B-Ly1 antibody and a Bcl-2 inhibitor and a MDM2 inhibitor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/